Download presentation
Presentation is loading. Please wait.
Published byLasse Korhonen Modified over 5 years ago
1
d a c b CD8 CD3 CD4 CD62L HLA-DR CD57 10% 85% 11% 76% 19% 60% 36% 66% 5% h e g f Supplemental Figure 1. Dasatinib patient with LGL lymphocytosis Dasatinib patient without LGL lymphocytosis Supplemental Figure 1. Immunophenotyping of peripheral blood (PB) cells. Immunophenotyping of PB lymphocytes of a dasatinib patient with LGL lymphocytosis (Pt 6 in Table 1, panels a-d) and of a control patient (Pt 6 in Table 3, panels e-h). Panels a, b, e, and f show gated CD3-positive cells and panels c, d, g and h gated CD8-positive cells. Percentage of positive cells from the gated population is marked in the dot plots.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.